Blocking stomach blood flow to fight obesity: a new approach?
NCT ID NCT04207424
First seen Apr 19, 2026 · Last updated Jun 23, 2026 · Updated 11 times
Summary
This study planned to test a procedure called bariatric embolization for people with morbid obesity who cannot have standard weight-loss surgery. The procedure involves injecting tiny particles into blood vessels near the stomach to reduce blood flow, which may lower hunger hormones and help with weight loss. However, the study was withdrawn before any participants were enrolled, so its safety and effectiveness remain unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MORBID OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Embolization of the gastro-epiploic arcade using polyvinyl-alcohol microparticles
What this could lead to
If it worked, this procedure could offer a less invasive option for weight loss in people who cannot have bariatric surgery.
What could go wrong
The study was withdrawn before enrolling anyone, so no results are available. The procedure carries risks like allergic reaction to contrast dye and potential complications from blocking blood vessels.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.